Brent Sabatini, SVP, Chief Accounting Officer at Vir Biotechnology, Inc. (VIR), sold 379 shares at $9.45 ($4K) on 2026-06-01, disclosed to the SEC on 2026-06-02.
Scheduled sale ($4k) by SVP, Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2026-02-24 | $14K | — | Filing → |
| VIR | SELL | 2026-02-18 | $12K | — | Filing → |
| VIR | SELL | 2025-02-25 | $15K | — | Filing → |